SEC ownership of Oculis Holding AG

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001953530.

Comparable stake leader

7. Cooperative Ua Lsp

Disclosed value leader

7. Cooperative Ua Lsp

Comparable rows

50/50

Latest evidence

31 Mar 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
7. Cooperative Ua Lsp
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
31 Mar 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001953530
Issuer location
Zug, Switzerland

Ownership snapshot

Top shareholders of Oculis Holding AG (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
7. Cooperative Ua Lsp
Disclosed value leader
7. Cooperative Ua Lsp
Comparable rows
50/50
Latest evidence
31 Mar 2026
13D/G 13F Lead comparable stake: 12% 13D/G row: 7. Cooperative Ua Lsp Showing 1-8 of 50 holder rows.

Quick read

7. Cooperative Ua Lsp leads the comparable SEC ownership view at 12%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens 7. Cooperative Ua Lsp's linked filing trail.
Comparable ownership Top 5
7. Cooperative Ua Lsp 12%
Pivotal bioVenture Partners Fund ... 4.9%
BVCF IV, L.P. 4.1%
EQT Fund Management S.a r.l. 10%
Gildi - lifeyrissjodur 4.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
7. Cooperative Ua Lsp
13D/G
LSP 7 Cooperatieve U.A.
12%
$184,808,317
6,950,294 shares
+$31,838,866 31 Mar 2026
Pivotal bioVenture Partners Fund I, L.P.
13D/G
Nan Fung Group Holdings Limited
4.9%
$49,946,544
2,815,476 shares
$0 30 Sep 2025
BVCF IV, L.P.
13D/G
4.1%
$73,082,691
2,436,902 shares
+$7,350,309 13 Feb 2026
EQT Fund Management S.a r.l.
13F
Company
13F
10%
$156,888,817
5,900,294 shares
31 Mar 2026
Gildi - lifeyrissjodur
13F
Company
13F
4.1%
$64,316,401
2,430,401 shares
31 Mar 2026
Aberdeen Group plc
13F
Company
13F
3%
$46,451,294
1,746,946 shares
31 Mar 2026
Pivotal bioVenture Partners Investment Advisor LLC
13F
Company
13F
2.9%
$44,678,725
1,680,283 shares
31 Mar 2026
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
2.3%
$35,782,907
1,345,728 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 22 Jul 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Recent insider transactions for Oculis Holding AG

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .